MedTrace Logo

Placebo Effect in the Treatment of Atopic Dermatitis

NCT02094287 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2015-09-18

No results posted yet for this study

Summary

The study is initiated in the indication of atopic dermatitis to study the impact of placebo in the treatment of pruritus. Classical conditioning and expectation via instructions/anticipation maintain the effect of placebo.

Conditions

Interventions

DRUG

dimetindene

receiving either dimetindene or a placebo (saline) via infusion

BEHAVIORAL

instruction

information about the drug dimetindene and its efficacy versus no information and unawareness of treatment influencing expectations of an efficient treatment

OTHER

conditioning

classical conditioning; experiencing and observing the efficiency of a drug manipulated by a conditioning process versus no learning experience.

Sponsors & Collaborators

  • University of Hamburg-Eppendorf

    collaborator OTHER

  • Margitta Worm

    lead OTHER

Principal Investigators

  • Margitta Worm, Prof. Dr. · Charite University, Berlin, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2013-11-30
Completion
2015-02-28

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02094287 on ClinicalTrials.gov